Uses:
- To treat anemia in chronic kidney failure.
- To treat anemia caused by chemotherapy.
Active ingredient: Darbepoetin Alfa.
Therapeutic effects:
- Darba 25mcg injection is an erythropoiesis-stimulating protein produced by recombinant DNA technology.
- It stimulates erythropoiesis by the same mechanism as erythropoietin, binding to progenitor stem cells and stimulating the production and differentiation of red blood cells.
- It works by causing the bone marrow to make more red blood cells.
Important information:
- Do not take Darba 25mcg injection if you are allergic to Darbepoetin alfa or any other ingredients, and have uncontrolled blood pressure.
- Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C.
- Inform your physician if you are pregnant or breastfeeding.
Side effects:
- Common: swelling in the face and body, low blood pressure, abdominal pain, shortness of breath, cough.
- Serious: heart problems, severe skin reactions, anemia, seizure attack, lung problems.
Safety advices:
- Pregnancy: there are no adequate and well-controlled studies on the use of Darba 25mcg injection in pregnant women. Inform your physician if you are pregnant, suspecting, or planning for pregnancy during the treatment.
- Breastfeeding: breastfeeding is not recommended in patients taking Darba 25mcg injection because the medicine passes into the breast milk in small amounts and may harm your baby.
- Lungs: it is unknown whether Darba 25mcg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
- Liver: Darba 25mcg injection is unsafe to administer in patients with liver problems. Dose adjustments are necessary. Inform your physician if you have any liver diseases or problems before initiating the therapy.
- Alcohol: it is unknown whether consuming alcohol is safe during the treatment with Darba 25mcg injection. Inform your doctor if you are a chronic drinker.
- Driving: Darba 25mcg injection will not make you feel tired, dizzy, or sleepy. It is safe to drive or operate heavy machinery after taking this medicine.
How to consume:
- This injection is to be given under the skin (subcutaneous).
- Your doctor, nurse, or other healthcare professional will train you on how to inject yourself with this pre-filled pen.
- Do not try to inject the pre-filled pen if you are not well-trained.
- Never inject the medicine into your vein.
- If you need help to inject the medicine, visit the nearby hospital or clinic.
Storage:
- Store in a refrigerator (2°C to 8°C).
- Do not freeze.
- Store in the original package to protect from light.
- Keep the injection away from the reach of children and pets.
- If you have missed any dosing appointments, inform your doctor and schedule immediately.
FAQs:
Can Darba 25mcg injection be used in patients with kidney failure who are undergoing dialysis? Yes, Darba 25mcg injection is commonly used in patients with kidney failure who are undergoing dialysis to manage anemia.
Can Darba 25mcg injection be used in patients with a history of heart disease? Darba 25mcg injection should be used with caution in patients with a history of heart disease, as it may increase the risk of certain cardiovascular events.
Can Darba 25mcg injection be used to treat anemia caused by nutritional deficiencies? Darba 25mcg injection is not typically used to treat anemia caused by nutritional deficiencies.
Can Darba 25mcg injection be used to treat anemia in patients undergoing radiation therapy? Darba 25mcg injection is used to treat anemia in patients undergoing chemotherapy, depending on the specific circumstances and the healthcare provider's recommendation.
Can Darba 25mcg injection interact with other medications? Darba 25mcg injection may interact with certain medications, such as blood thinners or immunosuppressants. It is important to inform the healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential interactions or adverse effects.
Fact Box:
- Molecule name: Darbepoetin Alfa.
- Therapeutic class: Antineoplastics.
- Pharmacological class: Hematopoietic growth factors.
- Indications:
- To treat anemia in chronic kidney failure.
- To treat anemia caused by chemotherapy.